eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) Receives Bullish Upgrade from Stifel Analyst, Stock Value Skyrockets
eFFECTOR Therapeutics, Inc. (EFTR), a clinical-stage biopharmaceutical company, experienced a surge in its stock value on May 26th. The boost […]